NIHR Maudsley BRC Blog

Our latest news & events

Going with the flow: study shows canals help boost your mood

The study, carried out by King’s College London, Nomad Projects and J & L Gibbons in partnership with the Canal & River Trust, shows that spending time by canals and rivers is linked to feeling happy and healthy.

By NIHR Maudsley BRC at 31 Aug 2022

Telling our stories of research through a new microsite

This week we are launching a new microsite - Stories of Research - to showcase the impactful work of our NIHR Maudsley BRC. Over the years, our Biomedical Research Centre has brought together scientists, clinicians, mental health professionals, industry, government, service users and carers to produce valuable research that is making difference to the lives of those affected by mental health conditions.

 

By NIHR Maudsley BRC at 7 Mar 2022

New research suggests a causal link between blood group and severe COVID-19

A new study has analysed over 3000 proteins to identify which are causally linked to the development of severe COVID-19. This is the first study to assess such a large number of proteins for their connection to COVID-19. The findings provide insight into potential new targets for approaches to treat and prevent severe COVID-19.

 

By NIHR Maudsley BRC at 3 Mar 2022

Young women with epilepsy at greater risk of stress induced seizures and drug resistance

New research part-funded by the NIHR Maudsley Biomedical Research Centre has established sex-specific factors that are linked to prognosis and drug resistance in juvenile myoclonic epilepsy (JME).

 

By NIHR Maudsley BRC at 23 Feb 2022

Next generation of rapid-acting antidepressants: Can ketamine help prevent suicide?

Naghmeh Nikkheslat is a Senior Research Associate at the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) who is working on a project funded by the NIHR Maudsley BRC to investigate the use of ketamine as a medication for depression. In this blog, she talks about her research into depression and the immune system and what we currently know about ketamine as an anti-inflammatory antidepressant in psychiatric emergencies.

By NIHR Maudsley BRC at 10 Jan 2022